Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Companion Animal Vaccines Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Companion Animal Vaccines Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Attenuated Live Vaccines
      • 1.3.3 Conjugate Vaccines
      • 1.3.4 Inactivated Vaccines
      • 1.3.5 Subunit Vaccines
      • 1.3.6 Toxoid Vaccines
      • 1.3.7 DNA Vaccines
      • 1.3.8 Recombinant Vaccines
    • 1.4 Market Segment by Application
      • 1.4.1 Global Companion Animal Vaccines Market Share by Application (2019-2025)
      • 1.4.2 Canine
      • 1.4.3 Avian
      • 1.4.4 Feline
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Companion Animal Vaccines Market Size
      • 2.1.1 Global Companion Animal Vaccines Revenue 2014-2025
      • 2.1.2 Global Companion Animal Vaccines Sales 2014-2025
    • 2.2 Companion Animal Vaccines Growth Rate by Regions
      • 2.2.1 Global Companion Animal Vaccines Sales by Regions 2014-2019
      • 2.2.2 Global Companion Animal Vaccines Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Companion Animal Vaccines Sales by Manufacturers
      • 3.1.1 Companion Animal Vaccines Sales by Manufacturers 2014-2019
      • 3.1.2 Companion Animal Vaccines Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Companion Animal Vaccines Revenue by Manufacturers (2014-2019)
      • 3.2.2 Companion Animal Vaccines Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Companion Animal Vaccines Market Concentration Ratio (CR5 and HHI)
    • 3.3 Companion Animal Vaccines Price by Manufacturers
    • 3.4 Key Manufacturers Companion Animal Vaccines Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Companion Animal Vaccines Market
    • 3.6 Key Manufacturers Companion Animal Vaccines Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Attenuated Live Vaccines Sales and Revenue (2014-2019)
      • 4.1.2 Conjugate Vaccines Sales and Revenue (2014-2019)
      • 4.1.3 Inactivated Vaccines Sales and Revenue (2014-2019)
      • 4.1.4 Subunit Vaccines Sales and Revenue (2014-2019)
      • 4.1.5 Toxoid Vaccines Sales and Revenue (2014-2019)
      • 4.1.6 DNA Vaccines Sales and Revenue (2014-2019)
      • 4.1.7 Recombinant Vaccines Sales and Revenue (2014-2019)
    • 4.2 Global Companion Animal Vaccines Sales Market Share by Type
    • 4.3 Global Companion Animal Vaccines Revenue Market Share by Type
    • 4.4 Companion Animal Vaccines Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Companion Animal Vaccines Sales by Application

    6 United States

    • 6.1 United States Companion Animal Vaccines Breakdown Data by Company
    • 6.2 United States Companion Animal Vaccines Breakdown Data by Type
    • 6.3 United States Companion Animal Vaccines Breakdown Data by Application

    7 European Union

    • 7.1 European Union Companion Animal Vaccines Breakdown Data by Company
    • 7.2 European Union Companion Animal Vaccines Breakdown Data by Type
    • 7.3 European Union Companion Animal Vaccines Breakdown Data by Application

    8 China

    • 8.1 China Companion Animal Vaccines Breakdown Data by Company
    • 8.2 China Companion Animal Vaccines Breakdown Data by Type
    • 8.3 China Companion Animal Vaccines Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Companion Animal Vaccines Breakdown Data by Company
    • 9.2 Rest of World Companion Animal Vaccines Breakdown Data by Type
    • 9.3 Rest of World Companion Animal Vaccines Breakdown Data by Application
    • 9.4 Rest of World Companion Animal Vaccines Breakdown Data by Countries
      • 9.4.1 Rest of World Companion Animal Vaccines Sales by Countries
      • 9.4.2 Rest of World Companion Animal Vaccines Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Bayer
      • 10.1.1 Bayer Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Companion Animal Vaccines
      • 10.1.4 Companion Animal Vaccines Product Introduction
      • 10.1.5 Bayer Recent Development
    • 10.2 Vetoquinol
      • 10.2.1 Vetoquinol Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Companion Animal Vaccines
      • 10.2.4 Companion Animal Vaccines Product Introduction
      • 10.2.5 Vetoquinol Recent Development
    • 10.3 Boehringer Ingelheim
      • 10.3.1 Boehringer Ingelheim Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Companion Animal Vaccines
      • 10.3.4 Companion Animal Vaccines Product Introduction
      • 10.3.5 Boehringer Ingelheim Recent Development
    • 10.4 Ceva
      • 10.4.1 Ceva Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Companion Animal Vaccines
      • 10.4.4 Companion Animal Vaccines Product Introduction
      • 10.4.5 Ceva Recent Development
    • 10.5 Eli Lilly
      • 10.5.1 Eli Lilly Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Companion Animal Vaccines
      • 10.5.4 Companion Animal Vaccines Product Introduction
      • 10.5.5 Eli Lilly Recent Development
    • 10.6 Heska
      • 10.6.1 Heska Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Companion Animal Vaccines
      • 10.6.4 Companion Animal Vaccines Product Introduction
      • 10.6.5 Heska Recent Development
    • 10.7 Merck
      • 10.7.1 Merck Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Companion Animal Vaccines
      • 10.7.4 Companion Animal Vaccines Product Introduction
      • 10.7.5 Merck Recent Development
    • 10.8 Merial
      • 10.8.1 Merial Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Companion Animal Vaccines
      • 10.8.4 Companion Animal Vaccines Product Introduction
      • 10.8.5 Merial Recent Development

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Companion Animal Vaccines Sales Channels
      • 11.2.2 Companion Animal Vaccines Distributors
    • 11.3 Companion Animal Vaccines Customers

    12 Market Forecast

    • 12.1 Global Companion Animal Vaccines Sales and Revenue Forecast 2019-2025
    • 12.2 Global Companion Animal Vaccines Sales Forecast by Type
    • 12.3 Global Companion Animal Vaccines Sales Forecast by Application
    • 12.4 Companion Animal Vaccines Forecast by Regions
      • 12.4.1 Global Companion Animal Vaccines Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Companion Animal Vaccines Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      Companion animal vaccines are used to stimulate an immune response in pets such as canine, avian and feline. These vaccine products are of various types such as Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines and Recombinant Vaccines.
      The Canine segment is the most attractive segment, recording an attractiveness index of 1.5 over the forecast period. The segment is projected to account for 51.0% value share by 2025.
      In 2019, the market size of Companion Animal Vaccines is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Companion Animal Vaccines.

      This report studies the global market size of Companion Animal Vaccines, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Companion Animal Vaccines sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Bayer
      Vetoquinol
      Boehringer Ingelheim
      Ceva
      Eli Lilly
      Heska
      Merck
      Merial

      Market Segment by Product Type
      Attenuated Live Vaccines
      Conjugate Vaccines
      Inactivated Vaccines
      Subunit Vaccines
      Toxoid Vaccines
      DNA Vaccines
      Recombinant Vaccines

      Market Segment by Application
      Canine
      Avian
      Feline

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Companion Animal Vaccines status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Companion Animal Vaccines manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Companion Animal Vaccines are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now